Table 2.
Variables | P |
Surgery alone |
Neoadjuvant CRT |
||
n | 5-yr survival (%) | n | 5-yr survival (%) | ||
Patients | NS | 108 | 20.4 | 190 | 25.6 |
Sex | |||||
Male | NS | 86 | 22.0 | 151 | 24.4 |
Female | NS | 22 | 13.8 | 39 | 32.6 |
Age (yr) | |||||
< 50 | NS | 11 | 58.3 | 38 | 33.7 |
50-70 | 0.015 | 65 | 15.8 | 124 | 24.7 |
> 70 | NS | 32 | 15.1 | 18 | 0.0 |
Histological subtype | |||||
Squamous cell carcinoma | NS | 55 | 31.3 | 100 | 19.8 |
Adenocarcinoma | 0.030 | 53 | 16.9 | 90 | 35.4 |
pN category | |||||
pN0 | NS | 27 | 36.5 | 98 | 41.6 |
pN1 | NS | 81 | 15.4 | 92 | 12.3 |
LN ratio | |||||
pN0 | NS | 27 | 36.5 | 98 | 41.6 |
LN ratio < 0.2 | NS | 52 | 23.7 | 69 | 10.3 |
LN ratio ≥ 0.2 | NS | 29 | 0.0 | 23 | 0.0 |
pM1 organ | NS | 11 | 0.0 | 8 | 0.0 |
R category | |||||
R0 | NS | 98 | 22.1 | 179 | 26.4 |
R1/R2 | NS | 10 | 0.0 | 11 | 0.0 |
Response after neoadjuvant therapy | |||||
Minor response | - | 112 | 11.4 | ||
Major response | - | 78 | 42.4 |